← all vendors
AssurX
AI score: 65 / 100
Viable with known tradeoffs
Configurable enterprise QMS for medical device, pharma, and regulated industries
Type: plug-ins / best-of-breed · Tech: modern · Budget: traditional ($70k–$350k/yr)
Core verticals: medical / bioscience, pharma / nutraceutical, aerospace / defense
General fit: food & beverage, OEM / industrial
Functions: quality, reporting / BI
Configurable QMS platform for FDA-regulated industries. Document control, CAPA, deviation management, and audit management for medical device and life sciences manufacturers.
Established QMS platform in FDA-regulated manufacturing with a highly configurable workflow engine. Particularly strong for companies needing both 21 CFR Part 11 compliance and extensive document lifecycle management. Less polished UX than newer entrants but deep regulatory compliance functionality.
AI score breakdown — 6 dimensions
SMB implementability 25%50
Mid-market to enterprise focus. Requires implementation project. Configuration-heavy platform — expect 3-6 months to go live. Regulatory expertise recommended.
Purpose fit 20%75
Comprehensive for regulated QMS: CAPA, document control, deviations, change management, audit management, risk management, training. FDA 21 CFR Part 11 compliant.
Tech modernity 20%62
Cloud and on-premises options. The platform is functional but UX reflects its legacy. Mobile access available. Workflow configurability is a strength.
Documentation quality 15%65
Good documentation for regulated implementations. White papers on FDA compliance, ISO 13485, and 21 CFR Part 820.
Real user sentiment 10%65
4.2/5 on G2. Long-tenured users in medical device and pharma appreciate depth. UX and implementation speed noted as areas for improvement.
TCO transparency 10%30
No public pricing. Contact required. Mid-to-enterprise range. Perpetual and SaaS options available.
validate / explore this score:
Perplexity
ChatGPT
Claude
Google